ADVERTISEMENT

European Biotechnology

1 / 4
EBM 3.2026 Autumn_cover

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

Get a free sample copy | Abo
2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

Get a free sample copy | Abo
3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

Get a free sample copy | Abo
4 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

Get a free sample copy | Abo

ADVERTISEMENT

ADVERTISEMENT

Sponsored Publications

1 / 4
AATec
autoimmune disease

AATec is pioneering a new ­approach to lung diseases

AATec is advancing ATL-105, a new recombinant version of alpha-1 antitrypsin for inhalation, into clinical development for chronic respiratory diseases. Rüdiger Jankowsky, CEO, and Gabriele Matschiner, … more ➔

2 / 4
Celonic
Biosimilars

Perfusion for next generation biosimilars

Perfusion is here, and it is rewriting the rules of biologics and biosimilar manufacturing. What was once experimental has become industrial reality: scalable, robust, regulatorily accepted, and commercially … more ➔

3 / 4
eppendorf-new_CDMO115x65V2
CRO & CDMO

Every process is different. Not the platform.

For CDMOs, flexible upstream platforms can help streamline process ­development while maintaining reproducibility and continuity across scales. more ➔

4 / 4
Professor Jacob George, Chief Medical and Scientific Officer at the MHRA presenting his keynote speech at Phacilitate Advanced Therapies Europe, 2026
Cell & Gene Therapy

Europe’s CGT advantage at risk

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, regulation, reimbursement, manufacturing and patient access to retain its global … more ➔

APPOINTMENTS

all appointments

ADVERTISEMENT

All news
newsletter_link

EVENT

Image_Stevenage
October 22 @ 11:00 - 16:00in Sycamore House, Stevenage, UK

Bioprocess Day, Science Connected: From R&D to Manufacturing

Bioprocess Day in Stevenage: an open house for everyone interested in upstream bioprocessing. No fixed agenda so you can join us whenever it fits your schedule. Register today for this free event, places are filling quickly! ➔